Quercetin attenuates skin inflammation and fibrosis in systemic sclerosis by targeting the RELA/c-Jun axis to suppress th17 cell responses
Frontiers in Immunology · 03.06.2026 · 17
DOI: 10.3389/fimmu.2026.1863530 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Immunology, online erschienen am 03.06.2026. Verfasst von Xiangzhen Kong und 21 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Shanghai TCM-Integrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Quercetin, Scleroderma, Systemic, Th17 Cells, Transcription Factor RelA. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Aberrant Th17 cell activation and interleukin-17 (IL-17) production drive skin inflammation and progressive fibrosis in systemic sclerosis (SSc). Identifying small molecules that can precisely modulate these pathogenic T cell responses is crucial for developing novel SSc therapies.
Methods
We utilized primary CD4 + T cells isolated from SSc patients and a bleomycin-induced SSc mouse model to evaluate the immunomodulatory effects of quercetin. Direct molecular target engagement was rigorously validated using Drug Affinity Responsive Target Stability (DARTS) and Cellular Thermal Shift Assay (CETSA).
Results
In patient-derived CD4 + T cells, quercetin treatment significantly suppressed the secretion of pro-inflammatory cytokines, including IL-17A and IFN-γ. Mechanistically, we demonstrated through DARTS and CETSA that quercetin directly binds to and stabilizes transcription factors RELA (p65) and c-Jun. This interaction effectively inhibited their phosphorylation and subsequent nuclear translocation, thereby dampening the IL-17 signaling cascade. In vivo , oral administration of quercetin significantly attenuated skin thickness, collagen deposition, and myofibroblast activation in SSc mice.
Conclusion
Our findings identify the RELA/c-Jun axis as a critical target for modulating T cell pathogenicity in SSc and suggest that quercetin holds therapeutic potential as an immunometabolic modulator to alleviate skin fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, Shanghai TCM-Integrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Human Phenome Institute, Fudan University, Shanghai, China.
- State Key Laboratory of Genetics and Development of Complex Phenotypes, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, Shanghai, China.
- Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
- Department of Pathology, Huadong Hospital, Fudan University, Shanghai, China.
- Department of Plastic and Aesthetic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Zitieren
APA
Kong, X., Leong, H., Du, M., Yang, J., Lai, J., Dong, Z., Hu, M., Gu, Y., Li, Y., Tan, Q., Chu, H., Liu, Q., Ma, Y., Xu, W., Li, S., Chen, Y., Chen, D., Chen, Y., Lu, W., …, & Wang, L. (2026). Quercetin attenuates skin inflammation and fibrosis in systemic sclerosis by targeting the RELA/c-Jun axis to suppress th17 cell responses. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1863530
Vancouver
Kong X, Leong H, Du M, Yang J, Lai J, Dong Z, et al. Quercetin attenuates skin inflammation and fibrosis in systemic sclerosis by targeting the RELA/c-Jun axis to suppress th17 cell responses. Frontiers in Immunology. 2026;17. doi:10.3389/fimmu.2026.1863530
BibTeX
@article{Kong2026,
author = {Kong, Xiangzhen and Leong, Hiochon and Du, Min and Yang, Jingyi and Lai, Jingzhen and Dong, Ziying and Hu, Menghua and Gu, Yifei and Li, Yexin and Tan, Qiaorui and Chu, Haiyan and Liu, Qingmei and Ma, Yanyun and Xu, Weihong and Li, Shanji and Chen, Yuxiao and Chen, Dongdong and Chen, Yuanyuan and Lu, Wei and Zhu, Jie and Wang, Jiucun and Wang, Lei},
title = {Quercetin attenuates skin inflammation and fibrosis in systemic sclerosis by targeting the RELA/c-Jun axis to suppress th17 cell responses},
journal = {Frontiers in Immunology},
year = {2026},
volume = {17},
doi = {10.3389/fimmu.2026.1863530}
}
EUVIMED